药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cortisone acetate
Ombitasvir
The serum concentration of Ombitasvir can be increased when it is combined with Methylene blue.
Cortisone acetate
Brefeldin A
The serum concentration of Methylene blue can be increased when it is combined with Brefeldin A.
Cortisone acetate
Deutetrabenazine
The risk or severity of adverse effects can be increased when Methylene blue is combined with Deutetrabenazine.
Cortisone acetate
Isavuconazole
The serum concentration of Methylene blue can be increased when it is combined with Isavuconazole.
Cortisone acetate
Pitolisant
The serum concentration of Pitolisant can be increased when it is combined with Methylene blue.
Cortisone acetate
Apalutamide
The serum concentration of Apalutamide can be decreased when it is combined with Methylene blue.
Cortisone acetate
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Methylene blue.
Cortisone acetate
Carfentanil, C-11
The risk or severity of adverse effects can be increased when Carfentanil, C-11 is combined with Methylene blue.
Cortisone acetate
Methylecgonine
The risk or severity of adverse effects can be increased when Methylecgonine is combined with Methylene blue.
Cortisone acetate
Drotebanol
The risk or severity of adverse effects can be increased when Drotebanol is combined with Methylene blue.
Cortisone acetate
Desomorphine
The risk or severity of adverse effects can be increased when Desomorphine is combined with Methylene blue.
Cortisone acetate
Ecgonine
The risk or severity of adverse effects can be increased when Ecgonine is combined with Methylene blue.
Cortisone acetate
Diamorphine
The risk or severity of adverse effects can be increased when Diamorphine is combined with Methylene blue.
Cortisone acetate
Abediterol
The risk or severity of adverse effects can be increased when Methylene blue is combined with Abediterol.
Cortisone acetate
PF-00610355
The risk or severity of adverse effects can be increased when Methylene blue is combined with PF-00610355.
Cortisone acetate
Hexoprenaline
The risk or severity of adverse effects can be increased when Methylene blue is combined with Hexoprenaline.
Cortisone acetate
Protokylol
The risk or severity of adverse effects can be increased when Methylene blue is combined with Protokylol.
Cortisone acetate
Bambuterol
The risk or severity of adverse effects can be increased when Methylene blue is combined with Bambuterol.
Cortisone acetate
Clenbuterol
The risk or severity of adverse effects can be increased when Methylene blue is combined with Clenbuterol.
Cortisone acetate
Piclozotan
The metabolism of Piclozotan can be decreased when combined with Methylene blue.